These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 18407390)

  • 1. Successful re-exposure to clozapine following uneventful rechallenge with olanzapine in a patient with neutropenia related to both agents.
    Wu SY; Liu CC; Hsieh MH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1089-90. PubMed ID: 18407390
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversible neutropenia with olanzapine following clozapine-induced neutropenia.
    Thangadurai P; Jyothi KS; Gopalakrishnan R; Kuruvilla A; Jacob KS
    Am J Psychiatry; 2006 Jul; 163(7):1298. PubMed ID: 16816247
    [No Abstract]   [Full Text] [Related]  

  • 3. Two-year follow-up of a patient with successful continuation of clozapine treatment despite morning pseudoneutropenia.
    Esposito D; Aouillé J; Rouillon F; Limosin F
    J Clin Psychiatry; 2004 Sep; 65(9):1281. PubMed ID: 15367056
    [No Abstract]   [Full Text] [Related]  

  • 4. Olanzapine appears haematologically safe in patients who developed blood dyscrasia on clozapine and risperidone.
    Dernovsek MZ; Tavcar R
    Int Clin Psychopharmacol; 2000 Jul; 15(4):237-8. PubMed ID: 10954065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible delayed onset olanzapine-associated leukopenia and neutropenia in a clozapine-naive patient on concomitant depot antipsychotic.
    Thinn SS; Liew E; May AL; Chua HC; Sim K
    J Clin Psychopharmacol; 2007 Aug; 27(4):394-5. PubMed ID: 17632225
    [No Abstract]   [Full Text] [Related]  

  • 6. Olanzapine-induced neutropenia in patients with history of clozapine treatment: two case reports from a state psychiatric institution.
    Teter CJ; Early JJ; Frachtling RJ
    J Clin Psychiatry; 2000 Nov; 61(11):872-3. PubMed ID: 11105743
    [No Abstract]   [Full Text] [Related]  

  • 7. Reappearance of tardive dystonia with olanzapine treated with clozapine.
    García-Lado I; García-Caballero A; Recimil MJ; Area R; Ozaita G; Lamas S
    Schizophr Res; 2005 Jul; 76(2-3):357-8. PubMed ID: 15949669
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic benign neutropenia/agranulocytosis associated with non-clozapine antipsychotics.
    Vila-Rodriguez F; Tsang P; Barr AM
    Am J Psychiatry; 2013 Oct; 170(10):1213-4. PubMed ID: 24084822
    [No Abstract]   [Full Text] [Related]  

  • 9. Agranulocytosis and neutropenia with typical and atypical neuroleptics.
    Hong X; Wang X
    Am J Psychiatry; 2001 Oct; 158(10):1736-7. PubMed ID: 11579015
    [No Abstract]   [Full Text] [Related]  

  • 10. Clozapine-induced neutropenia in children: management with lithium carbonate.
    Sporn A; Gogtay N; Ortiz-Aguayo R; Alfaro C; Tossell J; Lenane M; Gochman P; Rapoport JL
    J Child Adolesc Psychopharmacol; 2003; 13(3):401-4. PubMed ID: 14642024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign ethnic neutropenia and clozapine monitoring.
    Blackman G
    J Am Acad Child Adolesc Psychiatry; 2008 Aug; 47(8):967-8. PubMed ID: 18645423
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolongation of clozapine-induced neutropenia with olanzapine.
    Jagadheesan K; Mehrtens J
    Aust N Z J Psychiatry; 2007 Feb; 41(2):192. PubMed ID: 17464699
    [No Abstract]   [Full Text] [Related]  

  • 13. Rechallenging with clozapine following neutropenia: treatment options for refractory schizophrenia.
    Ghaznavi S; Nakic M; Rao P; Hu J; Brewer JA; Hannestad J; Bhagwagar Z
    Am J Psychiatry; 2008 Jul; 165(7):813-8. PubMed ID: 18593787
    [No Abstract]   [Full Text] [Related]  

  • 14. Lithium to allow clozapine prescribing in benign ethnic neutropenia.
    Nykiel S; Henderson D; Bhide G; Freudenreich O
    Clin Schizophr Relat Psychoses; 2010 Jul; 4(2):138-40. PubMed ID: 20643636
    [No Abstract]   [Full Text] [Related]  

  • 15. Clozapine-induced eosinophilia: subsequent neutropenia and corresponding allergic mechanisms.
    Lucht MJ; Rietschel M
    J Clin Psychiatry; 1998 Apr; 59(4):195-7. PubMed ID: 9590673
    [No Abstract]   [Full Text] [Related]  

  • 16. Fatal agranulocytosis: the use of olanzapine in a patient with schizophrenia and myelodysplasia.
    Stip E; Langlois R; Thuot C; Mancini-Marïe A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):297-300. PubMed ID: 16978752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing outcomes in clozapine rechallenge following neutropenia using human leukocyte antigen typing: A case report.
    Yamaki N; Hishimoto A; Otsuka I; Sasada T; Boku S; Saito T; Yasuda Y; Yamamori H; Ikeda M; Ikeda M; Sora I; Iwata N; Hashimoto R
    Psychiatry Clin Neurosci; 2017 Apr; 71(4):289-290. PubMed ID: 28097743
    [No Abstract]   [Full Text] [Related]  

  • 18. Case report of clozapine-induced neutropenia and rechallenge.
    Bavle A; Vidhyavathi M
    J Neuropsychiatry Clin Neurosci; 2015; 27(1):e61. PubMed ID: 25716496
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of preexisting diabetes with olanzapine.
    Littrell KH; Petty RG; Peabody CD; Hilligoss NM; Johnson CG
    J Clin Psychiatry; 2001 Sep; 62(9):733-4. PubMed ID: 11681771
    [No Abstract]   [Full Text] [Related]  

  • 20. Morning pseudoneutropenia during clozapine treatment.
    Esposito D; Aouillé J; Rouillon F; Limosin F
    World J Biol Psychiatry; 2003 Oct; 4(4):192-4. PubMed ID: 14608591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.